OptimizeRx (NASDAQ: OPRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of OptimizeRx (NASDAQ: OPRX) through any online brokerage.
The latest price target for OptimizeRx (NASDAQ: OPRX) was reported by Piper Sandler on Friday, July 1, 2022. The analyst firm set a price target for 29.00 expecting OPRX to rise to within 12 months (a possible 0.24% upside). 5 analyst firms have reported ratings in the last year.
The stock price for OptimizeRx (NASDAQ: OPRX) is $28.93 last updated July 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for OptimizeRx.
OptimizeRx’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for OptimizeRx.
OptimizeRx is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.